HNMT promotes hepatocellular carcinoma progression by up-regulation of VTN/ECM axis
Current Molecular Pharmacology · 2026 · 19 (1) · 133-142
DOI: 10.1016/j.cmp.2026.06.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Jiamu Qu und 10 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qu, J., Ye, D., Sun, Y., Fang, T., He, X., Ge, Q., Li, Z., Cao, X., Wang, Q., Li, G., & Sun, B. (2026). HNMT promotes hepatocellular carcinoma progression by up-regulation of VTN/ECM axis. Current Molecular Pharmacology, 19(1), 133-142. https://doi.org/10.1016/j.cmp.2026.06.003
Vancouver
Qu J, Ye D, Sun Y, Fang T, He X, Ge Q, et al. HNMT promotes hepatocellular carcinoma progression by up-regulation of VTN/ECM axis. Current Molecular Pharmacology. 2026;19(1):133-142. doi:10.1016/j.cmp.2026.06.003
BibTeX
@article{Qu2026,
author = {Qu, Jiamu and Ye, Dingde and Sun, Yang and Fang, Ting and He, Xianzhong and Ge, Qing and Li, Zhenwen and Cao, Xiang and Wang, Qiang and Li, Guoqiang and Sun, Beicheng},
title = {HNMT promotes hepatocellular carcinoma progression by up-regulation of VTN/ECM axis},
journal = {Current Molecular Pharmacology},
year = {2026},
volume = {19},
number = {1},
pages = {133--142},
doi = {10.1016/j.cmp.2026.06.003}
}
EUVIMED